Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology, ENDOCRINOLOGY and Hormonal range
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹349/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dapagliflozin 10mg + Metformin 1000mg + Sitagliptin 100mg tablet is a triple-action anti-diabetic formulation designed for the effective management of type 2 diabetes mellitus.
Dapagliflozin works by promoting glucose excretion through urine, Metformin reduces hepatic glucose production and improves insulin sensitivity, and Sitagliptin enhances incretin activity to increase insulin release and reduce glucagon levels.
This combination is commonly prescribed for patients requiring intensified glycemic control, including fasting and postprandial blood sugar management, helping reduce long-term diabetic complications.
With comprehensive glucose-lowering action, convenient once-daily dosing, and strong clinical acceptance, this formulation strengthens a diabetes management portfolio and supports consistent demand in advanced anti-diabetic therapy.
Common side effects may include nausea, diarrhea, urinary tract infections, increased urination, headache, or hypoglycemia when used with other antidiabetic agents. Rarely, lactic acidosis or ketoacidosis may occur.
Istalab DM 1000 Tablet is indicated for the management of type 2 diabetes mellitus in adults inadequately controlled with diet, exercise, and dual therapy, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Take with meals to reduce gastrointestinal discomfort. Regular monitoring of blood glucose, renal function, and hydration status is recommended during therapy.
Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.
Composition : Dapagliflozin 5mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Sitagliptin Phosphate I.P. 100mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 1000mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 500mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This triple antidiabetic combination has strong demand in the diabetes management segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes patients requiring advanced multi-drug therapy for better glycemic control in uncontrolled cases. It strengthens their antidiabetic and chronic care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dapagliflozin 10mg + Metformin 1000mg + Sitagliptin 100mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, repeat sales, and stable long-term diabetes market growth when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this antidiabetic triple combination can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.